Warning to Ozempic users: The side effect that may cause blindness
The U.S. Food and Drug Administration (FDA) announced yesterday (Monday) the addition of a warning to popular drugs for treating diabetes and obesity, including Ozempic, Wegovy, and Mounjaro, due to concerns of severe damage to…
Assessment
The FDA has added a warning to popular diabetes and weight loss drugs, including Ozempic, Wegovy, and Mounjaro, over a rare but serious risk of vision loss. The condition, NAION, involves damage to the optic nerve from reduced blood supply and can lead to sudden blindness. Patients using these medications should be aware of this newly flagged side effect and consult their doctors if they experience vision changes.